APO Research
Talk to an analyst

APO RESEARCH · REPORT

Allylamines Antifungal Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Allylamines Antifungal Drugs Industry Growth and Trends Forecast to 2032

23 December 2025124 pages

Choose your research edition.

Industry ResearchAllylamines Antifungal Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Allylamines Antifungal Drugs Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Allylamines Antifungal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allylamines Antifungal Drugs Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Allylamines Antifungal Drugs Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Allylamines Antifungal Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Allylamines Antifungal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Allylamines Antifungal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Allylamines Antifungal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Allylamines Antifungal Drugs include Chongqing Huapont Pharmaceutical, Yangtze River Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Tongyao Pharmaceutical Group, Teva, Shandong Chenxin Pharmaceutical, Sandoz, Qilu Pharmaceutical and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Allylamines Antifungal Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Allylamines Antifungal Drugs market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Allylamines Antifungal Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Allylamines Antifungal Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Allylamines Antifungal Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Allylamines Antifungal Drugs Market by Company

Chongqing Huapont Pharmaceutical

Yangtze River Pharmaceutical Group

Xiuzheng Pharmaceutical Group

Tongyao Pharmaceutical Group

Teva

Shandong Chenxin Pharmaceutical

Sandoz

Qilu Pharmaceutical

Novartis

Nanjing Chenggong Pharmaceutical

Mylan

Pfizer

Hunan Dinuo Pharmaceutical

Fuyuan Pharmaceutical

Bayer

Aobang Pharmaceutical

Gilead Sciences

Dr. Reddy's Laboratories

Cipla

Abbott Laboratories

Allylamines Antifungal Drugs Segment by Type

Terbinafine

Naftifine

Butenafine

Others

Allylamines Antifungal Drugs Segment by Application

Tinea Capitis

Dermatophytosis

Candidiasis

Tinea Versicolor

Others

Allylamines Antifungal Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allylamines Antifungal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allylamines Antifungal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allylamines Antifungal Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Allylamines Antifungal Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Allylamines Antifungal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Terbinafine Table 2. Major Company of Naftifine Table 3. Major Company of Butenafine Table 4. Major Company of Others Table 5. Global Allylamines Antifungal Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 7. Global Allylamines Antifungal Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Allylamines Antifungal Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Allylamines Antifungal Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Allylamines Antifungal Drugs Price by Type (2021-2026) & (USD/unit) Table 11. Global Allylamines Antifungal Drugs Sales by Type (2027-2032) & (units) Table 12. Global Allylamines Antifungal Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Allylamines Antifungal Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Allylamines Antifungal Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Allylamines Antifungal Drugs Price by Type (2027-2032) & (USD/unit) Table 16. North America Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 17. North America Allylamines Antifungal Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 19. Europe Allylamines Antifungal Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 21. Asia-Pacific Allylamines Antifungal Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 23. Latin America Allylamines Antifungal Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Allylamines Antifungal Drugs Sales by Type (2021-2026) & (units) Table 25. Middle East and Africa Allylamines Antifungal Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Allylamines Antifungal Drugs Industry Trends Table 27. Allylamines Antifungal Drugs Industry Drivers Table 28. Allylamines Antifungal Drugs Industry Opportunities and Challenges Table 29. Allylamines Antifungal Drugs Industry Restraints Table 30. Global Allylamines Antifungal Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Allylamines Antifungal Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Allylamines Antifungal Drugs Sales by Company (2021-2026) & (units) Table 33. Global Allylamines Antifungal Drugs Sales Share by Company (2021-2026) Table 34. Global Allylamines Antifungal Drugs Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Allylamines Antifungal Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Allylamines Antifungal Drugs Major Company Production Sites and Headquarters Table 37. Global Allylamines Antifungal Drugs Company, Product Type & Application Table 38. Global Allylamines Antifungal Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Allylamines Antifungal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Allylamines Antifungal Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Allylamines Antifungal Drugs Sales by Region (2021-2026) & (units) Table 43. Global Allylamines Antifungal Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Allylamines Antifungal Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Allylamines Antifungal Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Allylamines Antifungal Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Allylamines Antifungal Drugs Sales by Region (2027-2032) & (units) Table 48. Global Allylamines Antifungal Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Allylamines Antifungal Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Allylamines Antifungal Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Allylamines Antifungal Drugs Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Allylamines Antifungal Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 54. Global Allylamines Antifungal Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Allylamines Antifungal Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Allylamines Antifungal Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Allylamines Antifungal Drugs Price by Application (2021-2026) & (USD/unit) Table 58. Global Allylamines Antifungal Drugs Sales by Application (2027-2032) & (units) Table 59. Global Allylamines Antifungal Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Allylamines Antifungal Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Allylamines Antifungal Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Allylamines Antifungal Drugs Price by Application (2027-2032) & (USD/unit) Table 63. North America Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 64. North America Allylamines Antifungal Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 66. Europe Allylamines Antifungal Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 68. Asia-Pacific Allylamines Antifungal Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 70. Latin America Allylamines Antifungal Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Allylamines Antifungal Drugs Sales by Application (2021-2026) & (units) Table 72. Middle East and Africa Allylamines Antifungal Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Chongqing Huapont Pharmaceutical Company Information Table 74. Chongqing Huapont Pharmaceutical Business Overview Table 75. Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 77. Chongqing Huapont Pharmaceutical Recent Development Table 78. Yangtze River Pharmaceutical Group Company Information Table 79. Yangtze River Pharmaceutical Group Business Overview Table 80. Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio Table 82. Yangtze River Pharmaceutical Group Recent Development Table 83. Xiuzheng Pharmaceutical Group Company Information Table 84. Xiuzheng Pharmaceutical Group Business Overview Table 85. Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio Table 87. Xiuzheng Pharmaceutical Group Recent Development Table 88. Tongyao Pharmaceutical Group Company Information Table 89. Tongyao Pharmaceutical Group Business Overview Table 90. Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio Table 92. Tongyao Pharmaceutical Group Recent Development Table 93. Teva Company Information Table 94. Teva Business Overview Table 95. Teva Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Teva Allylamines Antifungal Drugs Product Portfolio Table 97. Teva Recent Development Table 98. Shandong Chenxin Pharmaceutical Company Information Table 99. Shandong Chenxin Pharmaceutical Business Overview Table 100. Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 102. Shandong Chenxin Pharmaceutical Recent Development Table 103. Sandoz Company Information Table 104. Sandoz Business Overview Table 105. Sandoz Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Sandoz Allylamines Antifungal Drugs Product Portfolio Table 107. Sandoz Recent Development Table 108. Qilu Pharmaceutical Company Information Table 109. Qilu Pharmaceutical Business Overview Table 110. Qilu Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Qilu Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 112. Qilu Pharmaceutical Recent Development Table 113. Novartis Company Information Table 114. Novartis Business Overview Table 115. Novartis Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Novartis Allylamines Antifungal Drugs Product Portfolio Table 117. Novartis Recent Development Table 118. Nanjing Chenggong Pharmaceutical Company Information Table 119. Nanjing Chenggong Pharmaceutical Business Overview Table 120. Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 122. Nanjing Chenggong Pharmaceutical Recent Development Table 123. Mylan Company Information Table 124. Mylan Business Overview Table 125. Mylan Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Mylan Allylamines Antifungal Drugs Product Portfolio Table 127. Mylan Recent Development Table 128. Pfizer Company Information Table 129. Pfizer Business Overview Table 130. Pfizer Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Pfizer Allylamines Antifungal Drugs Product Portfolio Table 132. Pfizer Recent Development Table 133. Hunan Dinuo Pharmaceutical Company Information Table 134. Hunan Dinuo Pharmaceutical Business Overview Table 135. Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 137. Hunan Dinuo Pharmaceutical Recent Development Table 138. Fuyuan Pharmaceutical Company Information Table 139. Fuyuan Pharmaceutical Business Overview Table 140. Fuyuan Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Fuyuan Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 142. Fuyuan Pharmaceutical Recent Development Table 143. Bayer Company Information Table 144. Bayer Business Overview Table 145. Bayer Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Bayer Allylamines Antifungal Drugs Product Portfolio Table 147. Bayer Recent Development Table 148. Aobang Pharmaceutical Company Information Table 149. Aobang Pharmaceutical Business Overview Table 150. Aobang Pharmaceutical Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Aobang Pharmaceutical Allylamines Antifungal Drugs Product Portfolio Table 152. Aobang Pharmaceutical Recent Development Table 153. Gilead Sciences Company Information Table 154. Gilead Sciences Business Overview Table 155. Gilead Sciences Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Gilead Sciences Allylamines Antifungal Drugs Product Portfolio Table 157. Gilead Sciences Recent Development Table 158. Dr. Reddy's Laboratories Company Information Table 159. Dr. Reddy's Laboratories Business Overview Table 160. Dr. Reddy's Laboratories Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Dr. Reddy's Laboratories Allylamines Antifungal Drugs Product Portfolio Table 162. Dr. Reddy's Laboratories Recent Development Table 163. Cipla Company Information Table 164. Cipla Business Overview Table 165. Cipla Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. Cipla Allylamines Antifungal Drugs Product Portfolio Table 167. Cipla Recent Development Table 168. Abbott Laboratories Company Information Table 169. Abbott Laboratories Business Overview Table 170. Abbott Laboratories Allylamines Antifungal Drugs Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. Abbott Laboratories Allylamines Antifungal Drugs Product Portfolio Table 172. Abbott Laboratories Recent Development Table 173. North America Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 174. North America Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 175. North America Allylamines Antifungal Drugs Sales Market Share by Country (2021-2026) Table 176. North America Allylamines Antifungal Drugs Sales Forecast by Country (2027-2032) & (units) Table 177. North America Allylamines Antifungal Drugs Sales Market Share Forecast by Country (2027-2032) Table 178. North America Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. North America Allylamines Antifungal Drugs Market Size by Country (2021-2026) & (US$ Million) Table 180. North America Allylamines Antifungal Drugs Market Share by Country (2021-2026) Table 181. North America Allylamines Antifungal Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. North America Allylamines Antifungal Drugs Market Share Forecast by Country (2027-2032) Table 183. Europe Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 184. Europe Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 185. Europe Allylamines Antifungal Drugs Sales Market Share by Country (2021-2026) Table 186. Europe Allylamines Antifungal Drugs Sales Forecast by Country (2027-2032) & (units) Table 187. Europe Allylamines Antifungal Drugs Sales Market Share Forecast by Country (2027-2032) Table 188. Europe Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Europe Allylamines Antifungal Drugs Market Size by Country (2021-2026) & (US$ Million) Table 190. Europe Allylamines Antifungal Drugs Market Share by Country (2021-2026) Table 191. Europe Allylamines Antifungal Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Europe Allylamines Antifungal Drugs Market Share Forecast by Country (2027-2032) Table 193. Asia-Pacific Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 194. Asia-Pacific Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 195. Asia-Pacific Allylamines Antifungal Drugs Sales Market Share by Country (2021-2026) Table 196. Asia-Pacific Allylamines Antifungal Drugs Sales Forecast by Country (2027-2032) & (units) Table 197. Asia-Pacific Allylamines Antifungal Drugs Sales Market Share Forecast by Country (2027-2032) Table 198. Asia-Pacific Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Asia-Pacific Allylamines Antifungal Drugs Market Size by Country (2021-2026) & (US$ Million) Table 200. Asia-Pacific Allylamines Antifungal Drugs Market Share by Country (2021-2026) Table 201. Asia-Pacific Allylamines Antifungal Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Asia-Pacific Allylamines Antifungal Drugs Market Share Forecast by Country (2027-2032) Table 203. Latin America Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 204. Latin America Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 205. Latin America Allylamines Antifungal Drugs Sales Market Share by Country (2021-2026) Table 206. Latin America Allylamines Antifungal Drugs Sales Forecast by Country (2027-2032) & (units) Table 207. Latin America Allylamines Antifungal Drugs Sales Market Share Forecast by Country (2027-2032) Table 208. Latin America Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. Latin America Allylamines Antifungal Drugs Market Size by Country (2021-2026) & (US$ Million) Table 210. Latin America Allylamines Antifungal Drugs Market Share by Country (2021-2026) Table 211. Latin America Allylamines Antifungal Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. Latin America Allylamines Antifungal Drugs Market Share Forecast by Country (2027-2032) Table 213. Middle East and Africa Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 214. Middle East and Africa Allylamines Antifungal Drugs Sales by Country (2021-2026) & (units) Table 215. Middle East and Africa Allylamines Antifungal Drugs Sales Market Share by Country (2021-2026) Table 216. Middle East and Africa Allylamines Antifungal Drugs Sales Forecast by Country (2027-2032) & (units) Table 217. Middle East and Africa Allylamines Antifungal Drugs Sales Market Share Forecast by Country (2027-2032) Table 218. Middle East and Africa Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 219. Middle East and Africa Allylamines Antifungal Drugs Market Size by Country (2021-2026) & (US$ Million) Table 220. Middle East and Africa Allylamines Antifungal Drugs Market Share by Country (2021-2026) Table 221. Middle East and Africa Allylamines Antifungal Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 222. Middle East and Africa Allylamines Antifungal Drugs Market Share Forecast by Country (2027-2032) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Allylamines Antifungal Drugs Distributors List Table 226. Allylamines Antifungal Drugs Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Allylamines Antifungal Drugs Image Figure 2. Global Allylamines Antifungal Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Allylamines Antifungal Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Allylamines Antifungal Drugs Sales (2021-2032) & (units) Figure 5. Terbinafine Image Figure 6. Global Terbinafine Sales YoY Growth (2021-2032) & (units) Figure 7. Naftifine Image Figure 8. Global Naftifine Sales YoY Growth (2021-2032) & (units) Figure 9. Butenafine Image Figure 10. Global Butenafine Sales YoY Growth (2021-2032) & (units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (units) Figure 13. Global Allylamines Antifungal Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Allylamines Antifungal Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Allylamines Antifungal Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Allylamines Antifungal Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Allylamines Antifungal Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Allylamines Antifungal Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Allylamines Antifungal Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Allylamines Antifungal Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Allylamines Antifungal Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Allylamines Antifungal Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Allylamines Antifungal Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Allylamines Antifungal Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Allylamines Antifungal Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Tinea Capitis Image Figure 28. Global Tinea Capitis Sales YoY Growth (2021-2032) & (units) Figure 29. Dermatophytosis Image Figure 30. Global Dermatophytosis Sales YoY Growth (2021-2032) & (units) Figure 31. Candidiasis Image Figure 32. Global Candidiasis Sales YoY Growth (2021-2032) & (units) Figure 33. Tinea Versicolor Image Figure 34. Global Tinea Versicolor Sales YoY Growth (2021-2032) & (units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (units) Figure 37. Global Allylamines Antifungal Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Allylamines Antifungal Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Allylamines Antifungal Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Allylamines Antifungal Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Allylamines Antifungal Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Allylamines Antifungal Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Allylamines Antifungal Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Allylamines Antifungal Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Allylamines Antifungal Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Allylamines Antifungal Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Allylamines Antifungal Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Allylamines Antifungal Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Allylamines Antifungal Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 50. North America Allylamines Antifungal Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Allylamines Antifungal Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Allylamines Antifungal Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Allylamines Antifungal Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 54. Europe Allylamines Antifungal Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Allylamines Antifungal Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Allylamines Antifungal Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Allylamines Antifungal Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 58. Asia-Pacific Allylamines Antifungal Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Allylamines Antifungal Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Allylamines Antifungal Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Allylamines Antifungal Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 62. Latin America Allylamines Antifungal Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Allylamines Antifungal Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Allylamines Antifungal Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Allylamines Antifungal Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 66. Middle East and Africa Allylamines Antifungal Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Allylamines Antifungal Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Allylamines Antifungal Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Allylamines Antifungal Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Allylamines Antifungal Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Terbinafine
  • Naftifine
  • Butenafine
  • Others
Applications
  • Tinea Capitis
  • Dermatophytosis
  • Candidiasis
  • Tinea Versicolor
  • Others
Companies covered
  • Chongqing Huapont Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • Xiuzheng Pharmaceutical Group
  • Tongyao Pharmaceutical Group
  • Teva
  • Shandong Chenxin Pharmaceutical
  • Sandoz
  • Qilu Pharmaceutical
  • Novartis
  • Nanjing Chenggong Pharmaceutical
  • Mylan
  • Pfizer
  • Hunan Dinuo Pharmaceutical
  • Fuyuan Pharmaceutical
  • Bayer
  • Aobang Pharmaceutical
  • Gilead Sciences
  • Dr. Reddy's Laboratories
  • Cipla
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Allylamines Antifungal Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Allylamines Antifungal Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Allylamines Antifungal Drugs Market by Type
  6. 1.3.1 Terbinafine
  7. 1.3.2 Naftifine
  8. 1.3.3 Butenafine
  9. 1.3.4 Others
  10. 1.4 Global Allylamines Antifungal Drugs Market Size by Type
  11. 1.4.1 Global Allylamines Antifungal Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Allylamines Antifungal Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Allylamines Antifungal Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Allylamines Antifungal Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Allylamines Antifungal Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Allylamines Antifungal Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Allylamines Antifungal Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Allylamines Antifungal Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Allylamines Antifungal Drugs Industry Trends
  2. 2.2 Allylamines Antifungal Drugs Industry Drivers
  3. 2.3 Allylamines Antifungal Drugs Industry Opportunities and Challenges
  4. 2.4 Allylamines Antifungal Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Allylamines Antifungal Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Allylamines Antifungal Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Allylamines Antifungal Drugs Price (2021-2026)
  4. 3.4 Global Allylamines Antifungal Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Allylamines Antifungal Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Allylamines Antifungal Drugs Company, Product Type & Application
  7. 3.7 Global Allylamines Antifungal Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Allylamines Antifungal Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Allylamines Antifungal Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Allylamines Antifungal Drugs Tier 1, Tier 2, and Tier 3
4 Allylamines Antifungal Drugs Regional Status and Outlook
  1. 4.1 Global Allylamines Antifungal Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Allylamines Antifungal Drugs Historic Market Size by Region
  3. 4.2.1 Global Allylamines Antifungal Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Allylamines Antifungal Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Allylamines Antifungal Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Allylamines Antifungal Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Allylamines Antifungal Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Allylamines Antifungal Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Allylamines Antifungal Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Allylamines Antifungal Drugs by Application
  1. 5.1 Allylamines Antifungal Drugs Market by Application
  2. 5.1.1 Tinea Capitis
  3. 5.1.2 Dermatophytosis
  4. 5.1.3 Candidiasis
  5. 5.1.4 Tinea Versicolor
  6. 5.1.5 Others
  7. 5.2 Global Allylamines Antifungal Drugs Market Size by Application
  8. 5.2.1 Global Allylamines Antifungal Drugs Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Allylamines Antifungal Drugs Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Allylamines Antifungal Drugs Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Allylamines Antifungal Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Allylamines Antifungal Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Allylamines Antifungal Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Allylamines Antifungal Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Allylamines Antifungal Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Huapont Pharmaceutical
  2. 6.1.1 Chongqing Huapont Pharmaceutical Company Information
  3. 6.1.2 Chongqing Huapont Pharmaceutical Business Overview
  4. 6.1.3 Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  6. 6.1.5 Chongqing Huapont Pharmaceutical Recent Developments
  7. 6.2 Yangtze River Pharmaceutical Group
  8. 6.2.1 Yangtze River Pharmaceutical Group Company Information
  9. 6.2.2 Yangtze River Pharmaceutical Group Business Overview
  10. 6.2.3 Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
  12. 6.2.5 Yangtze River Pharmaceutical Group Recent Developments
  13. 6.3 Xiuzheng Pharmaceutical Group
  14. 6.3.1 Xiuzheng Pharmaceutical Group Company Information
  15. 6.3.2 Xiuzheng Pharmaceutical Group Business Overview
  16. 6.3.3 Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
  18. 6.3.5 Xiuzheng Pharmaceutical Group Recent Developments
  19. 6.4 Tongyao Pharmaceutical Group
  20. 6.4.1 Tongyao Pharmaceutical Group Company Information
  21. 6.4.2 Tongyao Pharmaceutical Group Business Overview
  22. 6.4.3 Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
  24. 6.4.5 Tongyao Pharmaceutical Group Recent Developments
  25. 6.5 Teva
  26. 6.5.1 Teva Company Information
  27. 6.5.2 Teva Business Overview
  28. 6.5.3 Teva Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Allylamines Antifungal Drugs Product Portfolio
  30. 6.5.5 Teva Recent Developments
  31. 6.6 Shandong Chenxin Pharmaceutical
  32. 6.6.1 Shandong Chenxin Pharmaceutical Company Information
  33. 6.6.2 Shandong Chenxin Pharmaceutical Business Overview
  34. 6.6.3 Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  36. 6.6.5 Shandong Chenxin Pharmaceutical Recent Developments
  37. 6.7 Sandoz
  38. 6.7.1 Sandoz Company Information
  39. 6.7.2 Sandoz Business Overview
  40. 6.7.3 Sandoz Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sandoz Allylamines Antifungal Drugs Product Portfolio
  42. 6.7.5 Sandoz Recent Developments
  43. 6.8 Qilu Pharmaceutical
  44. 6.8.1 Qilu Pharmaceutical Company Information
  45. 6.8.2 Qilu Pharmaceutical Business Overview
  46. 6.8.3 Qilu Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Qilu Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  48. 6.8.5 Qilu Pharmaceutical Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Allylamines Antifungal Drugs Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Nanjing Chenggong Pharmaceutical
  56. 6.10.1 Nanjing Chenggong Pharmaceutical Company Information
  57. 6.10.2 Nanjing Chenggong Pharmaceutical Business Overview
  58. 6.10.3 Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  60. 6.10.5 Nanjing Chenggong Pharmaceutical Recent Developments
  61. 6.11 Mylan
  62. 6.11.1 Mylan Company Information
  63. 6.11.2 Mylan Business Overview
  64. 6.11.3 Mylan Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Mylan Allylamines Antifungal Drugs Product Portfolio
  66. 6.11.5 Mylan Recent Developments
  67. 6.12 Pfizer
  68. 6.12.1 Pfizer Company Information
  69. 6.12.2 Pfizer Business Overview
  70. 6.12.3 Pfizer Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Pfizer Allylamines Antifungal Drugs Product Portfolio
  72. 6.12.5 Pfizer Recent Developments
  73. 6.13 Hunan Dinuo Pharmaceutical
  74. 6.13.1 Hunan Dinuo Pharmaceutical Company Information
  75. 6.13.2 Hunan Dinuo Pharmaceutical Business Overview
  76. 6.13.3 Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  78. 6.13.5 Hunan Dinuo Pharmaceutical Recent Developments
  79. 6.14 Fuyuan Pharmaceutical
  80. 6.14.1 Fuyuan Pharmaceutical Company Information
  81. 6.14.2 Fuyuan Pharmaceutical Business Overview
  82. 6.14.3 Fuyuan Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Fuyuan Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  84. 6.14.5 Fuyuan Pharmaceutical Recent Developments
  85. 6.15 Bayer
  86. 6.15.1 Bayer Company Information
  87. 6.15.2 Bayer Business Overview
  88. 6.15.3 Bayer Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Bayer Allylamines Antifungal Drugs Product Portfolio
  90. 6.15.5 Bayer Recent Developments
  91. 6.16 Aobang Pharmaceutical
  92. 6.16.1 Aobang Pharmaceutical Company Information
  93. 6.16.2 Aobang Pharmaceutical Business Overview
  94. 6.16.3 Aobang Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Aobang Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
  96. 6.16.5 Aobang Pharmaceutical Recent Developments
  97. 6.17 Gilead Sciences
  98. 6.17.1 Gilead Sciences Company Information
  99. 6.17.2 Gilead Sciences Business Overview
  100. 6.17.3 Gilead Sciences Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Gilead Sciences Allylamines Antifungal Drugs Product Portfolio
  102. 6.17.5 Gilead Sciences Recent Developments
  103. 6.18 Dr. Reddy's Laboratories
  104. 6.18.1 Dr. Reddy's Laboratories Company Information
  105. 6.18.2 Dr. Reddy's Laboratories Business Overview
  106. 6.18.3 Dr. Reddy's Laboratories Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Dr. Reddy's Laboratories Allylamines Antifungal Drugs Product Portfolio
  108. 6.18.5 Dr. Reddy's Laboratories Recent Developments
  109. 6.19 Cipla
  110. 6.19.1 Cipla Company Information
  111. 6.19.2 Cipla Business Overview
  112. 6.19.3 Cipla Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Cipla Allylamines Antifungal Drugs Product Portfolio
  114. 6.19.5 Cipla Recent Developments
  115. 6.20 Abbott Laboratories
  116. 6.20.1 Abbott Laboratories Company Information
  117. 6.20.2 Abbott Laboratories Business Overview
  118. 6.20.3 Abbott Laboratories Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Abbott Laboratories Allylamines Antifungal Drugs Product Portfolio
  120. 6.20.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Allylamines Antifungal Drugs Sales by Country
  2. 7.1.1 North America Allylamines Antifungal Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Allylamines Antifungal Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Allylamines Antifungal Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Allylamines Antifungal Drugs Market Size by Country
  6. 7.2.1 North America Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Allylamines Antifungal Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Allylamines Antifungal Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Allylamines Antifungal Drugs Sales by Country
  2. 8.1.1 Europe Allylamines Antifungal Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Allylamines Antifungal Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Allylamines Antifungal Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Allylamines Antifungal Drugs Market Size by Country
  6. 8.2.1 Europe Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Allylamines Antifungal Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Allylamines Antifungal Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Allylamines Antifungal Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Allylamines Antifungal Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Allylamines Antifungal Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Allylamines Antifungal Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Allylamines Antifungal Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Allylamines Antifungal Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Allylamines Antifungal Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Allylamines Antifungal Drugs Sales by Country
  2. 10.1.1 South America Allylamines Antifungal Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Allylamines Antifungal Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Allylamines Antifungal Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Allylamines Antifungal Drugs Market Size by Country
  6. 10.2.1 South America Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Allylamines Antifungal Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Allylamines Antifungal Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Allylamines Antifungal Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Allylamines Antifungal Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Allylamines Antifungal Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Allylamines Antifungal Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Allylamines Antifungal Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Allylamines Antifungal Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Allylamines Antifungal Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Allylamines Antifungal Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Allylamines Antifungal Drugs Value Chain Analysis
  2. 12.1.1 Allylamines Antifungal Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Allylamines Antifungal Drugs Production Mode & Process
  7. 12.2 Allylamines Antifungal Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Allylamines Antifungal Drugs Distributors
  10. 12.2.3 Allylamines Antifungal Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst